Regulated information

2024 Calendar of financial communication

Vetoquinol published its calendar of financial communication for 2024.

Financial statements 2012

1.1CONSOLIDATED FINANCIAL STATEMENTS p.4

2012 ANNUAL RESULTS

SFAF Meeting March 27, 2013

Vétoquinol : 80 years striving for animal health worldwide

Founded in 1933, Vétoquinol is now a leading global animal health company.
The number 10 global animal health company and the third
largest in France, the Vétoquinol Group combines sustainability,
growth and independence in an increasingly competitive world
market.
Committed to the protection and well-being of both animals
and people, Vétoquinol creates, develops and sells veterinary
drugs and non-medical products all over the world.
The company is widely reputed for its expertise in the fields of infectious diseases, pain and inflammation in livestock (cattle and pigs) and pets (dogs and cats).
For over 80 years, Vétoquinol's pursuit of growth has been underpinned by strong values of team spirit, performance and the sharing of corporate culture and know-how with customers, vets, breeders, partners and employees alike.

ANNUAL RESULTS 2023 (slideshow)

01.2023 Highlights
02.2023 Consolidated financial statements
03.Strategy and outlook

Descriptif du programme de rachat d’actions propres soumis à
l’assemblée générale ordinaire du 22 mai 2013

Établi en application des dispositions des articles 241-1 et suivant du règlement général de l’Autorité des marchés financiers, le présent descriptif de programme de rachat d’actions propres a pour objet de décrire les finalités et les modalités du programme de rachat d’actions soumis à l’assemblée générale ordinaire du 22 mai 2013.

Buyback programs – January 2024

Monthly communication regarding buyback programs

Buyback programs - March 2024

Monthly communication regarding buyback programs

Half year financial report 2013

2013 Half year Financial Report

First half Results

2013 Half year results